P
Peter C. Black
Researcher at University of British Columbia
Publications - 405
Citations - 11696
Peter C. Black is an academic researcher from University of British Columbia. The author has contributed to research in topics: Bladder cancer & Cystectomy. The author has an hindex of 51, co-authored 331 publications receiving 8559 citations. Previous affiliations of Peter C. Black include Kyushu University & University of Mainz.
Papers
More filters
Journal ArticleDOI
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
Roland Seiler,Roland Seiler,Hussam Al-Deen Ashab,Nicholas Erho,Bas W.G. van Rhijn,Brian Winters,James Douglas,Kim E.M. van Kessel,Elisabeth E. Fransen van de Putte,Matthew Sommerlad,Natalie Q. Wang,Voleak Choeurng,Ewan A. Gibb,Beatrix Palmer-Aronsten,Lucia L. Lam,Christine Buerki,Elai Davicioni,Gottfrid Sjödahl,Jordan Kardos,Katherine A. Hoadley,Seth P. Lerner,David J. McConkey,Woonyoung Choi,William Y. Kim,Bernhard Kiss,George N. Thalmann,Tilman Todenhöfer,Simon J. Crabb,Scott North,Ellen C. Zwarthoff,Joost L. Boormans,Jonathan L. Wright,Marc A. Dall'Era,Michiel S. van der Heijden,Peter C. Black +34 more
TL;DR: Although cisplatin-based neoadjuvant chemotherapy improves patient outcomes, the results suggest that patients with basal tumors should be prioritized for NAC, and the first single-sample genomic subtyping classifier to subtype MIBC is discovered, which may be suitable for integration into routine clinical practice.
Journal ArticleDOI
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
Nicholas Erho,Anamaria Crisan,Ismael A. Vergara,Anirban P. Mitra,Mercedeh Ghadessi,Christine Buerki,Eric J. Bergstralh,Thomas M. Kollmeyer,Stephanie R. Fink,Zaid Haddad,Benedikt Zimmermann,Thomas Sierocinski,Karla V. Ballman,Timothy J. Triche,Peter C. Black,R. Jeffrey Karnes,George G. Klee,Elai Davicioni,Robert B. Jenkins +18 more
TL;DR: A genomic classifier was developed and validated in a large patient cohort enriched with prostate cancer metastasis patients and a rising PSA that went on to experience metastatic disease and may be useful for identification of aggressive prostate cancer.
Journal ArticleDOI
Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018
Marcus G. Cumberbatch,Ibrahim Jubber,Peter C. Black,Francesco Esperto,Jonine D. Figueroa,Ashish M. Kamat,Lambertus A. Kiemeney,Yair Lotan,Karl H. Pang,Debra T. Silverman,Ariana Znaor,James W.F. Catto +11 more
TL;DR: Evidence is emerging regarding gene-environment interactions, particularly for tobacco and occupational exposures, and standardisation of reporting may help improve epidemiologic evaluation of risk.
Journal ArticleDOI
Enhanced recovery after surgery (ERAS) protocols: Time to change practice?
TL;DR: Enhanced recovery after surgery (ERAS) protocols are multimodal perioperative care pathways designed to achieve early recovery after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery as discussed by the authors.
Journal ArticleDOI
Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population
R. Jeffrey Karnes,Eric J. Bergstralh,Elai Davicioni,Mercedeh Ghadessi,Christine Buerki,Anirban P. Mitra,Anamaria Crisan,Nicholas Erho,Ismael A. Vergara,Lucia L. Lam,Rachel Carlson,Darby J. S. Thompson,Zaid Haddad,Benedikt Zimmermann,Thomas Sierocinski,Timothy J. Triche,Thomas M. Kollmeyer,Karla V. Ballman,Peter C. Black,George G. Klee,Robert B. Jenkins +20 more
TL;DR: Results indicate that genomic information from the primary tumor can identify patients with adverse pathological features who are most at risk for metastasis and potentially lethal prostate cancer.